Strong Industry Presence With an annual revenue estimated between 250M and 500M and collaboration with high-profile organizations like the Congressional Diabetes Caucus, the Diabetes Patient Advocacy Coalition demonstrates significant influence in diabetes-related policy and advocacy, presenting opportunities for partnerships in medical devices and healthcare services.

Engaged Policy Focus DPAC's active involvement in shaping public policy and ensuring access to medications and diagnostic tools suggests potential for vendors specializing in healthcare policy solutions, advocacy technology, and patient engagement platforms.

Technology Adoption The use of modern web and SEO tools indicates a digitally savvy organization, creating opportunities for digital health companies to collaborate on educational campaigns, advocacy tools, and online patient support services.

Potential Collaborators With connections to prominent organizations like the American Diabetes Association and Diabetes Research Institute Foundation, DPAC is well-positioned for joint initiatives with companies involved in diabetes research, medical devices, or patient care technology.

Growing Advocacy Network DPAC’s focus on promoting health policies for the 37 million Americans with diabetes signals a large, receptive market for health technology solutions that improve disease management, medication safety, and patient adherence programs.